HCM
PFE icon

Hodges Capital Management’s Pfizer PFE Stock Holding History

Hodges Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,385
Closed -$358K – 217
2024
Q3 		$358K Sell
12,385
-1,246
-9% -$36.3K 0.02% 191
2024
Q2 		$381K Buy
13,631
+1,504
+12% +$41.4K 0.03% 189
2024
Q1 		$337K Buy
12,127
+1,752
+17% +$48.6K 0.02% 193
2023
Q4 		$299K Buy
10,375
+4,248
+69% +$128K 0.02% 191
2023
Q3 		$203K Buy
+6,127
New +$217K 0.02% 205
2023
Q2 		– Hold
0
– – – 176
2023
Q1 		– Sell
-13,929
Closed -$714K – 226
2022
Q4 		$714K Sell
13,929
-11,599
-45% -$556K 0.06% 164
2022
Q3 		$1.12M Sell
25,528
-9,608
-27% -$467K 0.18% 115
2022
Q2 		$1.84M Sell
35,136
-30,143
-46% -$1.54M 0.19% 103
2022
Q1 		$3.38M Sell
65,279
-42,166
-39% -$2.19M 0.27% 98
2021
Q4 		$6.34M Buy
107,445
+10,871
+11% +$539K 0.46% 77
2021
Q3 		$4.15M Buy
96,574
+89,384
+1,243% +$3.96M 0.31% 90
2021
Q2 		$282K Buy
7,190
+1,658
+30% +$64.5K 0.03% 211
2021
Q1 		$200K Buy
+5,532
New +$196K 0.03% 209
2019
Q1 		– Sell
-4,835
Closed -$200K – 243
2018
Q4 		$200K Buy
+4,835
New +$201K 0.02% 215
2017
Q4 		– Sell
-5,954
Closed -$202K – 264
2017
Q3 		$202K Buy
+5,954
New +$191K 0.01% 243
2017
Q1 		– Sell
-6,523
Closed -$201K – 294
2016
Q4 		$201K Sell
6,523
-5,559
-46% -$170K 0.01% 265
2016
Q3 		$388K Buy
12,082
+571
+5% +$19.1K 0.02% 222
2016
Q2 		$385K Buy
11,511
+3,882
+51% +$124K 0.02% 214
2016
Q1 		$215K Buy
7,629
+128
+2% +$3.66K 0.01% 251
2015
Q4 		$230K Buy
+7,501
New +$236K 0.01% 245

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hodges Capital Management's PFE Position: Q4 2024 in Review

Hodges Capital Management sold out of Pfizer (PFE) in Q4 2024, closing a stake of 12,385 shares — an estimated $358K sold.

Hodges Capital Management first reported a position in PFE in Q4 2015 and held it in 20 quarters. The position peaked at $6.34M in Q4 2021. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • Hodges Capital Management reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • Hodges Capital Management sold 12,385 Pfizer shares in Q4 2024, an estimated $358K.
  • Hodges Capital Management first reported a position in Pfizer in Q4 2015 and held it in 20 quarters.
  • Hodges Capital Management's Pfizer position peaked at $6.34M in Q4 2021.
  • 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Hodges Capital Management's 13F filing for Q4 2024, filed 24 Jan 2025.